Ovarian cancer cells are “addicted” to a family of proteins produced by the notorious oncogene, MYC, and blocking these Myc proteins halts cell proliferation in the deadliest cancer of the female reproductive system, according to a presentation by University of California, Berkeley scientists at the American Society for Cell Biology (ASCB) 48th Annual Meeting, Dec.
Full Post: Researchers stop ovarian cancer cell cycle in its tracks
Scientists have found a new way of accurately measuring the success of experimental cancer drugs, according to a study published in Cancer Research.
The researchers, funded by Cancer Research UK and the Medical Research Council, have developed a new imaging technique that can determine the levels of cancer drugs in normal and cancerous tissue.
A major challenge in drug development is finding the most effective dose - one that is high enough to kill cancer cells without being toxic to healthy cells.
Around 40 per cent of new anti-cancer drugs fail at the early stages because they are eliminated too quickly from the body or do not reach the blood. But scientists have found that the levels of drug in cancer tissue can determine how effective the drug is.
Professor Eric Aboagye, lead author of the study from Imperial College London, said: “This new technique will be a significant boost to scientists who work in drug discovery. Being able to accurately measure levels of a drug in different tissues, and understanding how this changes with different doses and schedules of the drug is crucial. We hope this will significantly reduce the costs of drug discovery - deciding to stop researching drugs that will be ineffective at an early stage could cut overall costs for drug discovery by up to 7 per cent.”
The new technique will use an imaging method called PET, or Positron Emission Tomography. A mildly radioactive tracer is attached to the cancer drug and injected into the patient. A mathematical formula is then used to calculate the levels of the drug in the patient’s blood and tissue.
Dr Lesley Walker, director of cancer information at Cancer Research UK, said: “Imaging is an invaluable tool in the fight against cancer. Being able to see what’s happening inside patients is vitally important in understanding how treatments are currently working and the best ways to improve them.
“Cancer Research UK has identified imaging research as a priority and we have recently invested Euro50 million over the next five years in partnership with other funding bodies to help us achieve our aim of improving the detection, diagnosis and treatment of cancer.”
http://info.cancerresearchuk.org
--------------------------------------------------------------------------------------------
Related Posts:
A new era of intelligent cancer drug development has spurred a leap in the proportion of drugs reaching patients, according to a study by Cancer Research UK scientists published in Nature Reviews Drug Discovery. Scientists obtained data on 974 cancer drugs in clinical development, and calculated that there was a probability that 18 per cent
Full Post: ‘Intelligent’ cancer drug development boosts success rates
Scientists have always wanted to take a closer look at biological systems and materials. From the magnifying glass to the electron microscope, they have developed ever-increasingly sophisticated imaging devices. Now, Niels de Jonge, Ph.D., and colleagues at Vanderbilt University and Oak Ridge National Laboratory (ORNL), add a new tool to the biology-watcher’s box. In the
Full Post: New technique images whole cells in liquid with a scanning transmission electron microscope
Breast-Specific Gamma Imaging (BSGI) has been proven to be a highly sensitive imaging technique for the diagnosis of invasive lobular carcinoma (ILC), a difficult to diagnose breast cancer. BSGI is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers. When compared to mammography, ultrasound and
Full Post: Molecular breast imaging technique shows greater sensitivity over mammography, ultrasound and MRI for difficult to diagnose breast cancer
A new technique to study genetic changes that can lead to breast cancer could be one step closer. The University of Nottingham has received £15,000 from the charity Breast Cancer Campaign to fill in one of the research gaps identified by the country’s top breast cancer experts in a recent study carried out by the
Full Post: New technique to study the genetics of breast cancer
CANCER RESEARCH UK scientists have linked cancer clues in faulty cells to provide a new route to cancer development, reveals a study published in Developmental Cell. Cancer is a disease caused by uncontrolled cell growth and division and understanding the complex molecular networks inside cells which regulate these processes is fundamental to understanding what goes
Full Post: Scientists establish completely new route to cancer development --------------------------------------------------------------------------------------------
